Skip to main content

Erratum to: Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer

The Original Article was published on 22 May 2017

Erratum

After publication of the original article [1] the authors found that the case number “n” had been incorrectly marked for each Gleason group in Figure 1g (Fig. 1g).

Fig. 1
figure 1

ENDOD1 is downregulated in PCa tissues with high Gleason scores. a-f Representative images showed the ENDOD1 immunostaining intensity. BPH tissues showed negative (a) and moderate (b) ENDOD1 staining. PCa tissues showed negative (c), strong (d), and moderate (e) and weak (f) ENDOD1 staining, respectively. Magnification 200×. g, Immunoreactivity scores (IRS) analysis of ENDOD1 in BPH tissues and PCa tissues. IRS were determined by multiplying the level of staining intensity (negative = 0, weak = 1, moderate = 2, strong = 3) and percentage of positively stained cells (0% = 0, <10% = 1, 11–50% = 2, 51–80% = 3, >80% = 4). Results indicated that PCa tissues with higher Gleason scores (Gleason score ≥ 7) showed significantly lower ENDOD1 expression than that with low Gleason score and BPH tissues. *P<0.05; **P<0.01

The biopsy Gleason group information had been used in the original article:

BPH: n=30

GS≤6: n=25

GS=7: n=13

GS≥8: n=12

Data should instead have been taken from the post-operative Gleason group, and the figures should therefore appear as the following in Figure 1g:

BPH: n=30

GS≤6: n=22

GS=7: n=10

GS≥8: n=18

A corrected, full version of Figure 1 with the above amendments has been included in this Erratum.

Corrected Figure 1

Reference

  1. Qiu J, Peng S, Si-Tu J, Hu C, Huang W, Mao Y, Qui W, Li K, Wang D. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer. BMC Cancer. 2017;17:360. doi:10.1186/s12885-017-3330-5.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ke Li or Dejuan Wang.

Additional information

The online version of the original article can be found under doi:10.1186/s12885-017-3330-5

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiu, J., Peng, S., Si-Tu, J. et al. Erratum to: Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer. BMC Cancer 17, 569 (2017). https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-017-3517-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-017-3517-9